Stock Scorecard



Stock Summary for Incyte Corp (INCY) - $57.10 as of 3/28/2024 4:12:57 PM EST

Total Score

18 out of 29

Currently on the following lists
Growth Stock List
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for INCY

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for INCY

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for INCY

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for INCY

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for INCY

Mesoblast ( MESO ) to File Pediatric GVHD Drug BLA, Stock Up 3/27/2024 3:00:00 PM
Why Is Incyte ( INCY ) Up 1.8% Since Last Earnings Report? 3/14/2024 3:30:00 PM
Incyte ( INCY ) Posts Positive Results on Opzelura From HS Study 3/12/2024 5:52:00 PM
MacroGenics ( MGNX ) Q4 2023 Earnings Call Transcript 3/8/2024 5:30:00 AM
Elanco Animal Health is Executing on Plan to Deliver for Shareholders 2/29/2024 6:08:00 PM
The Zacks Analyst Blog Highlights Moderna, RAPT Therapeutics, Iovance, Sarepta Therapeutics and Regeneron 2/23/2024 9:58:00 AM
Biotech Stock Roundup: MRNA's Q4 Results, RAPT Down on Study Results & Other Updates 2/22/2024 3:44:00 PM
AbCellera Biologics ( ABCL ) Q4 2023 Earnings Call Transcript 2/21/2024 4:00:00 AM
Polymerase Chain Reaction ( PCR ) Consumables Market Size & Share to Surpass USD 754.4 million by 2031 | Analysis by Transparency Market Research, Inc. 2/14/2024 1:10:00 PM
Incyte's ( INCY ) Q4 Earnings & Revenues Fall Shy of Estimates 2/13/2024 4:37:00 PM

Financial Details for INCY

Company Overview

Ticker INCY
Company Name Incyte Corp
Country USA
Description Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.
Sector Name TRADE & SERVICES
Industry Name SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Most Recent Quarter 12/31/2023
Next Earnings Date 4/30/2024

Stock Price History

Last Day Price 57.10
Last Day Price Updated 3/28/2024 4:12:57 PM EST
Last Day Volume 1,653,642
Average Daily Volume 1,868,420
52-Week High 76.04
52-Week Low 50.27
Last Price to 52 Week Low 13.59%

Valuation Measures

Trailing PE 21.69
Industry PE 34.70
Sector PE 43.11
5-Year Average PE -16.98
Free Cash Flow Ratio 3.51
Industry Free Cash Flow Ratio 50.55
Sector Free Cash Flow Ratio 89.92
Current Ratio Most Recent Quarter 3.75
Total Cash Per Share 16.28
Book Value Per Share Most Recent Quarter 23.14
Price to Book Ratio 2.49
Industry Price to Book Ratio 8.75
Sector Price to Book Ratio 9.32
Price to Sales Ratio Twelve Trailing Months 3.49
Industry Price to Sales Ratio Twelve Trailing Months 4.29
Sector Price to Sales Ratio Twelve Trailing Months 2.00

Share Statistics

Total Shares Outstanding 224,526,000
Market Capitalization 12,820,434,600
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.59%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 632.00%
Annual Earnings Growth 75.42%
Reported EPS 12 Trailing Months 2.65
Reported EPS Past Year 3.52
Reported EPS Prior Year 2.78
Net Income Twelve Trailing Months 597,599,000
Net Income Past Year 597,599,000
Net Income Prior Year 340,660,000
Quarterly Revenue Growth YOY 9.30%
5-Year Revenue Growth 14.44%

Balance Sheet

Total Cash Most Recent Quarter 3,656,043,000
Total Cash Past Year 3,656,043,000
Total Cash Prior Year 3,238,965,000
Net Cash Position Most Recent Quarter 3,656,043,000
Net Cash Position Past Year 3,656,043,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 18,300,000
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 5,189,837,000
Total Stockholder Equity Prior Year 4,370,119,000
Total Stockholder Equity Most Recent Quarter 5,189,837,000

Options

Put/Call Ratio 0.61
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.56
MACD Signal -0.38
20-Day Bollinger Lower Band 52.49
20-Day Bollinger Middle Band 59.02
20-Day Bollinger Upper Band 65.54
Beta 0.66
RSI 42.49
50-Day SMA 61.23
200-Day SMA 75.31

System

Modified 3/26/2024 10:36:57 PM EST